Katsura Y et al. |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles. |
1999 |
J. Med. Chem. |
pmid:10425101
|
Mera R et al. |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. |
1999 |
J. Clin. Gastroenterol. |
pmid:10405232
|
Horgan SE et al. |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. |
1999 |
J. Med. Microbiol. |
pmid:10403423
|
Lasko B et al. |
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. |
1998 |
J. Int. Med. Res. |
pmid:10399110
|
Inoue M et al. |
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]. |
1999 |
Jpn J Antibiot |
pmid:10396687
|
Hafner R et al. |
Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection. |
1999 |
J. Infect. Dis. |
pmid:10395860
|
Tsukamoto T et al. |
Biofilm in complicated urinary tract infection. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10394976
|
Raderer M et al. |
Successful symptomatic management of a patient with Ménétrier's disease with long-term antibiotic treatment. |
1999 Jul-Aug |
Digestion |
pmid:10394031
|
Stewart AK et al. |
Lack of response to short-term use of clarithromycin (BIAXIN) in multiple myeloma. |
1999 |
Blood |
pmid:10391696
|
Tomiyama Y et al. |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. |
1999 |
Kekkaku |
pmid:10386036
|
Houben MH et al. |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383522
|
Grimley CE et al. |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383520
|
Sieg A et al. |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383519
|
Calvet X et al. |
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383508
|
Ducóns JA et al. |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383507
|
Miwa H et al. |
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383502
|
Huang J and Hunt RH |
The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383500
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Hoellman DB et al. |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. |
1999 |
J. Antimicrob. Chemother. |
pmid:10382885
|
Schwartz HI et al. |
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. |
1999 |
Helicobacter |
pmid:10382126
|
Realdi G et al. |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. |
1999 |
Helicobacter |
pmid:10382124
|
Schubert ML |
H. pylori and nonulcer dyspepsia: not guilty as charged. |
1999 |
Gastroenterology |
pmid:10381939
|
Delle Cave M et al. |
Seven days of ranitidine bismuth citrate plus two antimicrobials for Helicobacter pylori eradication. |
1999 |
Ital J Gastroenterol Hepatol |
pmid:10379492
|
Vakil N |
Treatment of H. pylori infection: the reality. |
1998 Mar-Apr |
Yale J Biol Med |
pmid:10378357
|
Alvarez-Elcoro S and Enzler MJ |
The macrolides: erythromycin, clarithromycin, and azithromycin. |
1999 |
Mayo Clin. Proc. |
pmid:10377939
|
Bamford JT et al. |
Effect of treatment of Helicobacter pylori infection on rosacea. |
1999 |
Arch Dermatol |
pmid:10376693
|
Masa K et al. |
Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs. |
1999 |
Biol. Pharm. Bull. |
pmid:10375172
|
Behrens R et al. |
Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial. |
1999 |
Arch. Dis. Child. |
pmid:10373140
|
Bhasin DK et al. |
Helicobacter pylori eradication: comparison of three treatment regimens in India. |
1999 |
J. Clin. Gastroenterol. |
pmid:10372934
|
Iida H et al. |
Hypoglycemia induced by interaction between clarithromycin and disopyramide. |
1999 |
Jpn Heart J |
pmid:10370402
|
Wimsatt JH et al. |
Clarithromycin pharmacokinetics in the desert tortoise (Gopherus agassizii). |
1999 |
J. Zoo Wildl. Med. |
pmid:10367642
|
Moshkowitz M et al. |
The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia. |
1999 |
J Am Geriatr Soc |
pmid:10366173
|
Gooch WM et al. |
Loracarbef versus clarithromycin in children with acute otitis media with effusion. |
1999 |
Clin Ther |
pmid:10363736
|
Fost DA et al. |
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10359882
|
Jacoby EB and Porter KB |
Helicobacter pylori infection and persistent hyperemesis gravidarum. |
1999 |
Am J Perinatol |
pmid:10355915
|
Pilotto A et al. |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10355512
|
Son SW et al. |
The response of rosacea to eradication of Helicobacter pylori. |
1999 |
Br. J. Dermatol. |
pmid:10354058
|
Debets-Ossenkopp YJ et al. |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. |
1999 |
J. Antimicrob. Chemother. |
pmid:10350380
|
Champney WS and Tober CL |
Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348746
|
Sonnenberg A et al. |
Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer. |
1999 |
Am J Manag Care |
pmid:10345967
|
Dajani AI et al. |
One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases. |
1999 |
Digestion |
pmid:10343146
|
Abdul Aal GM et al. |
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week. |
1999 |
Digestion |
pmid:10343145
|
Nitu IC et al. |
Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses. |
1999 |
Clin Lab Haematol |
pmid:10342075
|
Champney WS and Tober CL |
Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. |
1999 |
Curr. Microbiol. |
pmid:10341075
|
Bocheńska-Marciniak M et al. |
[Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections]. |
1998 |
Pol. Arch. Med. Wewn. |
pmid:10335027
|
Le Gars L et al. |
Polyarthralgia-arthritis syndrome induced by low doses of rifabutin. |
1999 |
J. Rheumatol. |
pmid:10332992
|
Carbon C and Poole MD |
The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. |
1999 |
J Chemother |
pmid:10326741
|
Warheker PT et al. |
Successful treatment of saccular endophthalmitis with clarithromycin. |
1998 |
Eye (Lond) |
pmid:10326009
|
Woods GL et al. |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. |
1999 |
J. Clin. Microbiol. |
pmid:10325306
|
Vakil N and Cutler A |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10235192
|